Early Access — free while we kick the tires
EdgarHawk

Kayyem Jon Faiz

Director

Director
1 filing analyzed · 1 company · Latest 2024-11-22

Companies

Company Buys Sells Direction
Inhibrx Biosciences, Inc. INBX 4 0 Net buying

Activity

November 2024
medium
Buy
107,186 shares
$1,523,620
Significance 4/10

Director Kayyem Jon Faiz purchased 107,186 shares at blended average price $14.21 across 4 transactions on 2024-11-19 and 2024-11-20, investing $1,523,619.52.

Director Faiz purchased 107,186 shares totaling $1,523,619.52 at a blended average price of $14.21, a significant personal investment. However, his track record presents a cautionary pattern: across 7 prior open-market buys, the average 30-day return was -22.7% and 90-day return was -14.2%, with a 90-day win rate of 0.00%. His five prior purchases at INBX specifically showed similarly negative outcomes, with all five trades experiencing negative 90-day returns ranging from -7.4% to -20.2%. The stock is currently trading at $14.08, down 64.4% from its 52-week high of $39.56, and the company faces significant headwinds: revenue of $0.00 in the latest quarter and a net loss of $-43,864,000.00. The purchase occurs against a backdrop of consistent underperformance in this insider's prior trades and fundamental weakness at the company.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access